This study is accepting new patients by invitation only
Long-term Safety and Tolerability of BHV-7000
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at UCLA UCSD
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Biohaven Therapeutics Ltd.
- ID
- NCT06443463
- Phase
- Phase 2 Epilepsy Research Study
- Study Type
- Interventional
- Participants
- Expecting 660 study participants
- Last Updated